Research
UAB’s Cathleen Cummings is searching for and identifying temples in Nagpur, India, before they are forgotten by history.

Strategic hiring, support for faculty research and multidisciplinary collaboration propel UAB’s Department of Psychology to a 12 percent increase in federal funding.

UAB study suggests individuals diagnosed with autism spectrum disorder may not be more prone to cyber phishing attacks compared to those without the disorder.
A UAB dentist has developed a new filling using antibiotics and nitric oxide for root canal treatment that can help heal the canal more effectively.

Up to now, it has not been clear if these cells might be useful to combat influenza infections or even if they exist at all.

A UAB study suggests that psychedelic drugs have a positive effect on antisocial, criminal behavior, warranting investigation of psychedelics as a crime reduction therapy.
This knowledge can provide targets in the search for novel bone-loss therapeutics to treat osteoporosis.
UAB researchers want to create new treatments for these banes of cardiovascular disease.
Researchers have discovered the mechanism of this control, with implications for developmental biology, the immune response and cancer dysregulation.
The August issue of the journal focused on genomics in rheumatic diseases, the complex effort to understand the genetic underpinnings of more than 100 diseases that affect joints and muscles.
Undergraduate research opportunity attracts students from across the United States.
This novel method improves purification of complex proteins by 10- to 500-fold, and it may aid both research and large-scale industrial production.
Hundreds of students will present academic pursuits in cutting-edge research topics.
This type of lab course is part of a national undergraduate biology education reform effort.
This is the first demonstration of donor microbes persisting in the recipient following fecal transplant, a finding made possible by a novel method to “fingerprint” individual strains of bacteria.
Michael Birrer, a leading medical oncologist at Harvard University, will take the reins as the new director of the UAB Comprehensive Cancer Center, succeeding the retiring Edward Partridge.
At a time when medical cannabis and cannabis-based products are gaining traction in the treatment of seizures, one of UAB’s CBD oil investigators serves as a guest editor for a special research journal devoted to cannabinoid research.
Allostery, a fundamental means of regulating enzymes, is crucial for living cells.
Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
A UAB symposium on cardiovascular tissue engineering brought together some of the best in the business in this rapidly developing field of translational medicine.
Page 1 of 56